Optimising the Cancer Management of Older Patients by Early and Specific Geriatric Interventions.
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: WARNING Pack.
- Who it may be relevant to
- Registry conditions: Neoplasms (Cancer / Tumors), Geriatric Oncology. Basic parameters: from 75 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Optimization of Care in Older Patients With Cancer Undergoing Treatment in Day Care Unit, Through a Specific Management Based on Early Geriatric Warning Signs: a Multicenter Randomized Trial.
Overview
The WARNING project proposes a new care organisation for older patients with cancer. The aim is to optimise management in daycare with early detection signs of geriatric syndromes and specific interventions. This prevention package, called the 'WARNING Pack', includes a specific multimodal geriatric management guide for the oncologist (physician form), based on patient-reported early geriatric warning signs (patient form). Primary outcome is to reduce the risk of deterioration in global quality of life at 6 months during treatment and to prevent the onset of geriatric syndromes.
Interventions
- Other WARNING Pack
This prevention package, called the 'WARNING Pack', includes a specific multimodal geriatric management guide for the oncologist (physician form), based on patient-reported early geriatric warning signs (patient form).
Primary outcome measures
- Proportion of patients with unchanged or improved global quality of life between M0 and M6. [Time frame: 6 month]
Eligibility criteria
Inclusion criteria
- Patients aged ≥75 years.
- Patients with confirmed solid cancer or haematological malignancy, regardless of
- the site of the tumour (single or multiple), - the duration of the disease, or - the treatment modality (adjuvant, neoadjuvant, locally advanced, palliative metastatic).
- Patients starting a first line of systemic treatment or a new line of treatment after a break of at least six months.
- Patients treated in a daycare hospital.
- Persons belonging to or benefiting from a social security scheme.
- Free and informed consent after receiving appropriate information.
Exclusion criteria
- Patients under legal protection (guardianship, curatorship).
- Persons with enhanced protection, i.e. persons deprived of their liberty by a judicial or administrative decision, persons in a health or social care institution, persons under legal protection and patients in emergency situations.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Supportive care
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT07704307 · 2026-A01098-43